Videos and webinars

Webinars

Metrion Webinar – Dr Kris Kahlig

May 2022

Overview

Dr Kris Kahlig is the Head of Biology at Praxis Precision Medicines Inc. a clinical stage biopharmaceutical company translating genetic insights into the development of therapies for patients affected by CNS disorders. Kris presented at the Metrion Webinar series on “Using Dynamic Action Potential Clamp Modelling of Nav1.2 Variants to Support the Prediction of Clinical Phenotype in DEE”.

The webinar took place on Thursday 5th May 2022 at 16:00 BST.

Discover more…

Metrion Webinar – Dr Greg Carr

February 2022

Overview

We are delighted to present the fourth speaker in our “Ion Channels in Drug Discovery” webinar series – Dr Greg Carr from the Lieber Institute for Brain Development. Greg’s presentation was entitled: “A role for hERG potassium channels in cognitive function”

The webinar took place on Thursday 3rd February 2022 at 16:00 BST.

Discover more…

Metrion Webinar – Professor David Sheppard

November 2021

Overview

We are delighted to present the third speaker in our webinar series – Professor David Sheppard from the University of Bristol. David’s presentation was focused on Cystic Fibrosis and his talk was “Cystic Fibrosis: Rescuing Faulty Channels with Targeted Therapies”.

The webinar took place on Tuesday 30th November 2021 at 16:00 BST.

Discover more…

Metrion Webinar – Professor Stephen Tucker

September 2021

Overview

We are delighted to present the second speaker in our webinar series – Professor Stephen Tucker from the Department of Physics at the University of Oxford. Stephen speaking on the topic of the TASK-1 K2P channel and his talk will be entitled “Defective X-gating caused by de novo mutations in the TASK-1 K2P channel (KCNK3) underlies a developmental disorder with sleep apnea”.

The webinar took place on Thursday 16th September 2021 at 16:00 BST.

Discover more…

An overview of Metrion Biosciences

December 2020

Overview

Metrion Biosciences’ CEO Dr Andrew Southan presents an overview of Metrion Biosciences, highlighting the company’s vision, expertise and services. December 10th, 2020.

Discover more…

Video

Designing multiple assay protocols for ligand-gated ion channels using the stacked-tip feature on the Patchliner and SP384i platforms

October 2020

Overview

Marc Rogers (Metrion CSO) presents a talk at the Nanion Virtual User Meeting 2020 entitled “Designing multiple assay protocols for ligand-gated ion channels using the stacked-tip feature on the Patchliner and SP384i platforms”. 14th October 2020.

Discover more…

Webinar

Validation and optimization of automated patch-clamp voltage-gated Ca2+ channel assays

May 2020

Overview

Marc Rogers (Metrion CSO) takes part in a collaborative webinar with Nanion Technologies entitled “Validation and optimization of automated patch-clamp voltage-gated Ca2+ channel assays”.

Discover more…

Video

The benefits of targeting ion channels for pain and some of the hurdles in developing successful ion channel modulators

December 2019

Overview

As part of the the LabTube meets series of interviews Marc Rogers, Metrion Biosciences CSO, outlines the benefits of targeting ion channels for pain and some of the hurdles in developing successful ion channel modulators.

Discover more…

Video

SR Live event during Metrion’s 2018 Syndicate Room finance round

February 2018

Overview

Presentation by Marc Rogers (Metrion CSO) at the 8th February 2018 SR Live event during Metrion’s 2018 Syndicate Room finance round.

Discover more…

Video

CiPA update: in vitro cardiac ion channel screens, in silico models and stem cell iPS cardiomyocyte assays for proarrhythmia risk prediction

June 2016

Overview

Presentation by Marc Rogers (Metrion CSO) at the June 2016 Sophion Ion Channel Modulation Symposium, Clare College, Cambridge (UK). CiPA update: in vitro cardiac ion channel screens, in silico models and stem cell iPS cardiomyocyte assays for proarrhythmia risk prediction.

Discover more…

Video

Using high quality HTS automated patch-clamp data from human cardiac ion channels and in silico action potential modelling to cost-effectively predict QP prolongation and arrhythmia risk for CiPA

October 2015

Overview

Presentation by Marc Rogers (Metrion CSO) at the September 2015 Safety Pharmacological Society, Prague. Using high quality HTS automated patch-clamp data from human cardiac ion channels and in silico action potential modelling to cost-effectively predict QP prolongation and arrhythmia risk for CiPA.

Discover more…

Wave Background thinner 01 1
Metrion Ion Channel Screening Icon 01

Let’s work together

What are your specific ion channel and assay needs?

If you have any questions or would to like discuss your specific assay requirements, we will put you directly in touch with a member of our scientific team. Contact us today to discover more.